Royal Bank of Canada’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.82M Sell
54,996
-7,880
-13% -$256K ﹤0.01% 3161
2025
Q4
$2.06M Buy
62,876
+36,369
+137% +$894K ﹤0.01% 3122
2025
Q3
$473K Buy
26,507
+2,449
+10% +$35.5K ﹤0.01% 4516
2025
Q2
$262K Sell
24,058
-13,985
-37% -$183K ﹤0.01% 4958
2025
Q1
$704K Buy
38,043
+4,723
+14% +$85.2K ﹤0.01% 3738
2024
Q4
$549K Sell
33,320
-1,925
-5% -$27.3K ﹤0.01% 4014
2024
Q3
$494K Buy
35,245
+6,643
+23% +$73.5K ﹤0.01% 4107
2024
Q2
$207K Sell
28,602
-521
-2% -$3.56K ﹤0.01% 4739
2024
Q1
$235K Sell
29,123
-15,357
-35% -$138K ﹤0.01% 4552
2023
Q4
$303K Buy
44,480
+9,024
+25% +$50.2K ﹤0.01% 4719
2023
Q3
$177K Buy
35,456
+26,462
+294% +$183K ﹤0.01% 4927
2023
Q2
$82K Buy
8,994
+549
+7% +$5.12K ﹤0.01% 5474
2023
Q1
$79K Sell
8,445
-4,239
-33% -$38.8K ﹤0.01% 5349
2022
Q4
$126K Buy
12,684
+6,555
+107% +$72.8K ﹤0.01% 5277
2022
Q3
$74K Buy
6,129
+5,266
+610% +$52.7K ﹤0.01% 5501
2022
Q2
$7K Sell
863
-2,148
-71% -$18.4K ﹤0.01% 6506
2022
Q1
$24K Sell
3,011
-6,981
-70% -$60.3K ﹤0.01% 6501
2021
Q4
$94K Sell
9,992
-1,206
-11% -$14.5K ﹤0.01% 5991
2021
Q3
$176K Buy
11,198
+1,536
+16% +$27.6K ﹤0.01% 5282
2021
Q2
$208K Buy
9,662
+780
+9% +$15.8K ﹤0.01% 5038
2021
Q1
$181K Sell
8,882
-460
-5% -$9.09K ﹤0.01% 5028
2020
Q4
$167K Buy
9,342
+3,036
+48% +$44.6K ﹤0.01% 4984
2020
Q3
$73K Sell
6,306
-791
-11% -$9.19K ﹤0.01% 5150
2020
Q2
$66K Buy
7,097
+1,885
+36% +$16.9K ﹤0.01% 5091
2020
Q1
$54K Sell
5,212
-6,931
-57% -$88.2K ﹤0.01% 5115
2019
Q4
$217K Buy
12,143
+312
+3% +$4.61K ﹤0.01% 4583
2019
Q3
$148K Sell
11,831
-374
-3% -$6.16K ﹤0.01% 4616
2019
Q2
$242K Buy
12,205
+990
+9% +$21.2K ﹤0.01% 4357
2019
Q1
$236K Buy
11,215
+7,725
+221% +$141K ﹤0.01% 4245
2018
Q4
$72K Sell
3,490
-10,486
-75% -$328K ﹤0.01% 4902
2018
Q3
$511K Buy
13,976
+11,097
+385% +$484K ﹤0.01% 3893
2018
Q2
$145K Sell
2,879
-299
-9% -$13.2K ﹤0.01% 4602
2018
Q1
$116K Buy
3,178
+714
+29% +$21.9K ﹤0.01% 4616
2017
Q4
$70K Sell
2,464
-391
-14% -$9.23K ﹤0.01% 5012
2017
Q3
$55K Buy
2,855
+1,992
+231% +$33.5K ﹤0.01% 5357
2017
Q2
$14K Sell
863
-180
-17% -$2.43K ﹤0.01% 5675
2017
Q1
$11K Sell
1,043
-2,254
-68% -$23K ﹤0.01% 5911
2016
Q4
$29K Buy
3,297
+2,834
+612% +$24.4K ﹤0.01% 5559
2016
Q3
$4K Hold
463
﹤0.01% 6012
2016
Q2
$3K Hold
463
﹤0.01% 6052
2016
Q1
$2K Hold
463
﹤0.01% 6116
2015
Q4
$2K Hold
463
﹤0.01% 6350
2015
Q3
$2K Hold
463
﹤0.01% 6369
2015
Q2
$1K Hold
463
﹤0.01% 6427
2015
Q1
$2K Hold
463
﹤0.01% 5898
2014
Q4
$2K Buy
+463
New +$1.35K ﹤0.01% 5962

Other funds holding AXGN

Royal Bank of Canada's AXGN Position: Q1 2026 in Review

Royal Bank of Canada reduced its Axogen (AXGN) stake by 13% in Q1 2026, selling an estimated $256K and leaving 54,996 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #3161.

Royal Bank of Canada first reported a position in AXGN in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.06M in Q4 2025. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Royal Bank of Canada held 54,996 shares of Axogen worth $1.82M as of Q1 2026.
  • Royal Bank of Canada sold 7,880 Axogen shares in Q1 2026, an estimated $256K.
  • Axogen made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3161 holding.
  • Royal Bank of Canada first reported a position in Axogen in Q4 2014 and has held it in 46 quarters since.
  • Royal Bank of Canada's Axogen position peaked at $2.06M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.